Učitavanje...
Cancer immunotherapy with CAR-T cells – behold the future
Cellular therapy is a key tool to treat haematological malignancies. Over 40,000 allogeneic and autologous haematopoietic stem cell transplants (HSCTs) are performed annually across Europe.(1) Since 2017, a new T cell therapy, chimeric antigen receptor-T (CAR-T) cells have been licensed outside clin...
Spremljeno u:
| Izdano u: | Clin Med (Lond) |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Royal College of Physicians
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6334043/ https://ncbi.nlm.nih.gov/pubmed/30072559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.18-4-324 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|